494 related articles for article (PubMed ID: 16801132)
1. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.
Higashiyama S; Iwabuki H; Morimoto C; Hieda M; Inoue H; Matsushita N
Cancer Sci; 2008 Feb; 99(2):214-20. PubMed ID: 18271917
[TBL] [Abstract][Full Text] [Related]
3. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
4. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor.
Witters L; Scherle P; Friedman S; Fridman J; Caulder E; Newton R; Lipton A
Cancer Res; 2008 Sep; 68(17):7083-9. PubMed ID: 18757423
[TBL] [Abstract][Full Text] [Related]
6. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.
Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM
Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509
[TBL] [Abstract][Full Text] [Related]
7. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
Graus-Porta D; Beerli RR; Daly JM; Hynes NE
EMBO J; 1997 Apr; 16(7):1647-55. PubMed ID: 9130710
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer.
Fridman JS; Caulder E; Hansbury M; Liu X; Yang G; Wang Q; Lo Y; Zhou BB; Pan M; Thomas SM; Grandis JR; Zhuo J; Yao W; Newton RC; Friedman SM; Scherle PA; Vaddi K
Clin Cancer Res; 2007 Mar; 13(6):1892-902. PubMed ID: 17363546
[TBL] [Abstract][Full Text] [Related]
9. Targeting ligand cleavage to inhibit the ErbB pathway in cancer.
Zhou BB
Ann N Y Acad Sci; 2005 Nov; 1059():56-60. PubMed ID: 16382043
[TBL] [Abstract][Full Text] [Related]
10. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
11. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
12. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
13. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
Uchida T; Wada K; Akamatsu T; Yonezawa M; Noguchi H; Mizoguchi A; Kasuga M; Sakamoto C
Biochem Biophys Res Commun; 1999 Dec; 266(2):593-602. PubMed ID: 10600548
[TBL] [Abstract][Full Text] [Related]
14. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
Komurasaki T; Toyoda H; Uchida D; Morimoto S
Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
[TBL] [Abstract][Full Text] [Related]
15. An oxidative stress mechanism mediates chelerythrine-induced heparin-binding EGF-like growth factor ectodomain shedding.
Kim J; Lin J; Adam RM; Lamb C; Shively SB; Freeman MR
J Cell Biochem; 2005 Jan; 94(1):39-49. PubMed ID: 15490481
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear translocation signaling of HB-EGF carboxy-terminal fragment and mucosal defense through cell proliferation and migration in digestive tracts.
Tanida S; Kataoka H; Mizoshita T; Shimura T; Kamiya T; Joh T
Digestion; 2010; 82(3):145-9. PubMed ID: 20588025
[TBL] [Abstract][Full Text] [Related]
17. Shedding light on sheddases: role in growth and development.
Kheradmand F; Werb Z
Bioessays; 2002 Jan; 24(1):8-12. PubMed ID: 11782944
[TBL] [Abstract][Full Text] [Related]
18. EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists.
Carpenter G
Sci STKE; 2000 Jan; 2000(15):pe1. PubMed ID: 11865189
[TBL] [Abstract][Full Text] [Related]
19. The epidermal growth factor receptor ligands at a glance.
Schneider MR; Wolf E
J Cell Physiol; 2009 Mar; 218(3):460-6. PubMed ID: 19006176
[TBL] [Abstract][Full Text] [Related]
20. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
